Holen Sie sich die Stockscreener-App
46.43
11.16%
-5.83
Vorhandelsmarkt:
46.78
0.35
+0.75%
Schlusskurs vom Vortag:
$52.26
Offen:
$50.82
24-Stunden-Volumen:
8.80M
Relative Volume:
1.52
Marktkapitalisierung:
$8.34B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$-302.91M
KGV:
-27.02
EPS:
-1.7182
Netto-Cashflow:
$-219.93M
1W Leistung:
-8.00%
1M Leistung:
-14.13%
6M Leistung:
-39.43%
1J Leistung:
-20.85%
1-Tages-Spanne:
$45.84
$52.23
1-Wochen-Bereich:
$45.84
$54.75
52-Wochen-Spanne:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
46.43 | 9.38B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
172.61 | 29.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
57.40 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
88.67 | 7.19B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
63.62 | 4.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Underperform |
| 2026-04-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI to present at Goldman Sachs healthcare conference - scanx.trade
Geode Capital Management LLC Boosts Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Lelezard
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth Narrative - Yahoo Finance
TD Cowen raises Tempus AI stock price target on genomics strength - Investing.com
ARK's Stock Pick: $LLY & $TEM Hold Strong as AI Growth Stocks Plunge — Defensive Biotech Shines - Moomoo
TEM Technical Analysis & Stock Price Forecast - Intellectia AI
AI that predicts clinical outcomes? Tempus AI in focus after ASCO data reveal - MSN
Tempus (TEM) Gets Double-Digit Boost from New Partnerships - Insider Monkey
Tempus AI (NASDAQ:TEM) Trading Up 9.3%Time to Buy? - MarketBeat
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Tempus AI Stock Pops As FDA Win Fuels Growth Story - StocksToTrade
Why Tempus AI Stock Is Surging On Thursday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Australia
Tempus AI (TEM) Jumps As FDA Win Fuels Bullish Momentum - timothysykes.com
Why Is Tempus (TEM) Down 11.2% Since Last Earnings Report? - Yahoo Finance
$Tempus AI (TEM.US)$ thanks for the ride [Drool] - Moomoo
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI launches digital pathology open-source consortium - Investing.com UK
Tempus AI (TEM) director Epstein sells 250 shares in pre-planned trade - Stock Titan
Tempus AI Stock (TEM) Opinions on Analyst Coverage Initiation - Quiver Quantitative
Tempus AI launches digital pathology open-source consortium By Investing.com - Investing.com Nigeria
Tempus AI Launches Open-Source Digital Pathology Consortium With Yale New Haven Health - geneonline.com
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members - Yahoo Finance
Canaccord Genuity Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM) - The Globe and Mail
$Tempus AI (TEM.US)$ someday… you will be wonderful again… - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at Wolfe Research - MarketBeat
Canaccord reiterates Tempus AI stock rating citing growth potential By Investing.com - Investing.com South Africa
Canaccord reiterates Tempus AI stock rating citing growth potential - Investing.com
Tempus AI, Inc. $TEM Shares Bought by Lingotto Investment Management LLP - MarketBeat
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY) - The Globe and Mail
AXQ Capital LP Buys Shares of 26,002 Tempus AI, Inc. $TEM - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Wolfe Research initiates Tempus AI stock coverage with Peerperform By Investing.com - Investing.com South Africa
Wolfe Research initiates Tempus AI stock coverage with Peerperform - Investing.com UK
Tempus AI (TEM) Launches Next-Gen Sequencing Test for Oncology - GuruFocus
Stifel Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $60 - Moomoo
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Tempus xH test finds 40% more genomic findings than standard care - Stock Titan
Needham Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $75 - Moomoo
Tempus AI's (TEM) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Tempus AI: Buy Rating Reiterated as Analyst Maintains $75 Price Target on Durable Growth and Improving Financial Profile - TipRanks
William Blair Maintains Tempus AI(TEM.US) With Hold Rating - Moomoo
Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development - Moomoo
Tempus AI, Inc. (TEM) Stock Analysis: Exploring a 33.15% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development - BioSpace
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tempus Ai Inc-Aktie (TEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LEFKOFSKY ERIC P | CEO and Chairman |
May 27 '26 |
Sale |
46.70 |
166,250 |
7,763,312 |
8,808,533 |
3.07%
7.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):